Skip to content

An fMRI investigation of the neural substrate of cognitive insight in non-clinical subjects

An fMRI investigation of the neural substrate of cognitive insight in non-clinical subjects - Cognitive insight in non-clinical subjects

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON43071
Enrollment
200
Registered
2016-11-23
Start date
2016-12-06
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

zelf-reflectie en open staan voor mening van anderen it involves healthy subjects. This study is not aimed at a certain disorder

Interventions

Cognitive insight
Mindfulness
Processing of self-related social feedback

Sponsors

Neurowetenschappen
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: * Being right-handed (based on Edinburgh Handedness inventory questionnaire) * Age 18-65 * Normal (or corrected to normal) vision * fMRI-compatible * Capable of giving informed consent * Fluent in written and spoken Dutch

Exclusion criteria

Exclusion criteria: * Not matching any of the inclusion criteria * Matching any criterion in the fMRI exclusion list, including, but not limited to, claustrophobia, infarctions, epilepsy or family history of epilepsy, presence of metal inside the body, presence of electric/electronic devices inside the body (pacemakers, etc.), presence of intracardial lines, (suspicion of) pregnancy, tattoo(s) that contain red pigment, any risk of having metal particles in the eyes * Non-removable dentures * Use of medication that can influence task performance. For example, medication that target blood pressure or heart rate (e.g. beta-blockers). Also, use of antidepressants, anxiolytic, and anti-epileptic drugs * Use of drugs such as cannabis, XTC or other recreational drugs * Presence or history of neurological, psychiatric or substance dependence disorder * Previous mindfulness or other formal meditation experience

Design outcomes

Primary

MeasureTime frame
The main study parameters are brain activation and/or connectivity during tasks, and brain (functional and structural) connectivity during resting state, in relation to cognitive insight. Blood-oxygen-level-dependent (BOLD) signal will be measured during the performance of two different tasks and at rest using fMRI. In addition, a special kind of diffusion-weighted imaging (DWI) called diffusion tensor imaging (DTI) will be used to examine the relationship between the integrity of white matter tracts and cognitive insight, while structural MRI scans will be used to examine grey matter volume in relationship to cognitive insight.

Secondary

MeasureTime frame
Secondary study parameters are cognitive test scores on the Sustained Attention to Response Task (sustained attention, inhibition and meta-awareness).

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)